eLetters is an online forum for ongoing peer review. To submit an eLetter please go to the article you wish to respond to and click on the link that reads "eLetters: Submit a Response." Submission of eLetters are open to all health care professionals and experts in related fields.

eLetters to:

ARTICLES:
Walter K. Kraft, Eric Gibson, Kevin Dysart, Vidula S. Damle, Jennifer L. LaRusso, Jay S. Greenspan, David E. Moody, Karol Kaltenbach, and Michelle E. Ehrlich
Sublingual Buprenorphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Trial
Pediatrics 2008; 122: e601-e607 [Abstract] [Full text] [PDF]
*eLetters: Submit a response to this article

eLetters published:

[Read eLetters] Appreciate an update
Peyton Gaunt   (9 September 2009)

Appreciate an update 9 September 2009
Top
Peyton Gaunt,
Pediatrician
Pediatric Interim Care Center

Send letter to journal:
Re: Appreciate an update

pgaunt{at}comcast.net Peyton Gaunt

I have been the medical director of the Kent WA Pediatric Interim Care Center, a unique volunteer center for the treatment of babies withdrawing from drugs, since its inception 19 years ago. We routinely treat about 15 babies at a time, many with neonatal morphine for NAS from opiates. I am interested if you have continued to use buprenorphine and if you have had any more patients with seizures during treatment with it and if you have succeeded in reducing the ethanol content. Thanks for the update. Peyton Gaunt, M.D.

Conflict of Interest:

None declared